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Abstract: This paper reports details about the synthesis of a series of novel functionalized 
symmetrical bis-heterocyclic compounds containing a thieno[2,3-b]thiophene motif.   
Bis-thiazole derivatives 2, 3a-c and thiazolo[3,2-a]pyridine derivatives 4a-c are achieved. 
The hitherto unknown dihydrothiophene derivatives 6a-d via bis-pyridimium salt 5 are 
obtained. Additionally, the novel hydrazonothieno[2,3-b]thiophene derivatives 10a-c are 
obtained  via bis-tosylacetylthieno[2,3-b]thiophene derivative 9. All compounds are 
characterized by 
1H-, 
13C-NMR, GCMS, IR, and UV-vis spectrometry. These compounds 
represent a new class of sulfur and nitrogen containing heterocycles that should also be of 
interest as new materials. 
Keywords: thiazolo[3,2-a]pyridine; dihydrothiphene; thieno[2,3-b]thiophene; symmetrical 
bis-heterocycle 
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1. Introduction 
Thienothiophene derivatives have been developed for different purposes in the pharmaceutical field 
and have been tested as potential antitumor, antiviral, antibiotic, and antiglaucoma drugs, or as 
inhibitors of platelet aggregation [1–5]. We have been interested for some time in the chemical and 
biological properties of thienothiophene derivatives [6–12]. On the other hand thiophene derivatives 
represent a class of important and well-studied heterocycles [13,14]. Thiazoles and their derivatives have 
attracted continuing interest over the years because of their diverse biological activities [15,16]. They 
have found application in drug development for the treatment of allergies [15], hypertension, 
inflammation, schizophrenia, bacterial and HIV infections [17–21]. On the other hand  substituted 
thiazolo pyridines represent an important class of annulated heterocycles with diverse types of 
pharmaceutical [22] and pesticide activity [23–28]. We have found that the bis-2-bromoacetylthieno[2,3-
b]thiophene derivative 1, is a versatile, readily accessible building block for the synthesis of several new 
heterocyclic compounds of biological potency. 
2. Results and Discussion 
Refluxing of equimolar amounts of the bis-2-bromoacetylthieno[2,3-b]thiophene derivative 1 and 
cyanothioacetamide in ethanol and in the presence of a catalytic amount of TEA, afforded the 
corresponding bis-thiazole derivative 2. The structure of the isolated cycloadduct was identified as 
2,2'-(4,4'-(3,4'-dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(thiazole-4,2-diyl))diacetonitrile (2)  on the 
basis of its elemental analyses and spectral data. The IR spectrum of the reaction product exhibited 
absorption bands at 2259  cm
−1
 due to the nitrile group. The 
1H-NMR spectrum of compound 2 
revealed three singlets at δ 2.21, 3.79 and 7.80 due to methyl, methelene and CH thiazol protons, 
respectively. The reactivity of compound 2 towards some heterocyclic aldehydes was also investigated. 
Thus, the treatment of compound 2 with aldehyde derivatives in ethanol and in the presence of a 
catalytic amount of TEA afforded bis-thiazole derivatives 3a-c. The 
1H-NMR spectrum of 3a showed 
three singlets at δ 2.28, 8.50 and 8.84 due to CH3, CH and CH thiazol protons respectively, in addition 
to an aromatic multiplet in the region 6.99–7.40. Compounds 3a-c were alternatively obtained   
by the reaction of the treatment of bis-2-bromoacetylthieno[2,3-b]thiophene derivative 1 with   
2-cyano-2-arylmethylene-thioacetamide derivatives in ethanol/DMF (Scheme 1). Treatment of the   
bis-thiazole derivatives 3a-c with malononitrile afforded the corresponding thiazolo pyridine 
derivatives 4a-c (Scheme 1). Compounds 4a-c were alternatively obtained by reaction of the treatment 
of bis-thiazole derivative 2 with 2-cyano-2-arylmethylenethioacetamide derivatives in ethanol/DMF 
(Scheme 1). On the other hand, compounds 4a-c underwent a thermal intramolecular cyclization 
reaction  via an initial Michael type adduct. The IR spectrum of compound 4b, taken as a typical 
example of the prepared series, revealed absorption bands at 2241, 2193, and 3383–3320 cm
−1
 
corresponding to two nitrile and amino functions, respectively. Its 
1H-NMR spectrum showed signals at 
δ 2.31, 4.57, 4.72, and 9.23, due to CH3, CH2, NH2 and CH thiazol protons respectively, in addition to an 
aromatic multiplet in the region 6.99–7.40. An aromatic multiplet in the region δ 7.49–7.60 was also 
found. Its mass spectrum revealed a molecular ion peak at m/z 789. Int. J. Mol. Sci. 2012, 13  5037 
 
 
Scheme 1. Synthesis of thiazolo[3,2-a]pyridine derivatives 4a-c. 
 
Our study was extended to include the synthesis of new bis-dihydrothiophene derivatives   
6a-d. Thus, the bis-2-bromoacetylthieno[2,3-b]thiophene  1 was refluxed in a mixture of absolute 
ethanol, pyridine and THF for 1 h to give a single product of bis-pyridimium salt 5 as examined by 
TLC. Elemental analyses and mass spectrum analysis of the isolated product were completely in 
agreement with the molecular formula C22H20Br2N2O2S2. The structure of the product is assumed to be 
5 according to the rationale outlined in Scheme 2 in 95% yield. The compound reacts with   
(E)-3-amino-2-benzyl-3-mercaptoacrylonitrile which is in resonating structure with (E)-2-cyano-3-
phenylprop-2-enethioamide in refluxing ethanol which undergoes intramolecular cyclization to give 
compound 6a in 86% yield. The 
1H-NMR of compound 6a was free of pyridine protons and exhibited 
two characteristic doublet signal at 4.40, 4.70 pmm integrated for 2H (for the C–H proton of the 
dihydrothiophene moiety). In addition, one broad signal at 4.19 ppm was integrated for 2H proton (for 
the NH2). Furthermore, CN and NH absorption appeared at 2187, 3450 cm
–1, respectively, in the IR.  
It is noteworthy to mention here that the bis-dihydrothiophene derivatives 6b-d with different 
moieties were also prepared from bis-pyridimium salt 5 and the corresponding aryl-mercaptoacrylonitrile 
derivatives but in very good yield, as depicted in Scheme 2. 
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Scheme 2. Synthesis of dihydrothiophene derivatives 6a-d. 
 
There has been continuous interest in the synthesis of a new hydrazono system containing sulfone 
moiety because it holds considerable interest relative to the preparation of organic intermediates and 
physiologically active compounds. Thus, when the bis-2-bromoacetylthieno[2,3-b]thiophene 1 was 
treated with sodium 4-methylbenzenesulfinate in a mixture of absolute ethanol and DMF under reflux 
for 4 h, it afforded a white crystalline product, namely the bis-tosylacetylthieno[2,3-b]thiophene 
derivative 9 in a 97% yield, and its use as key intermediate for the synthesis of a wide variety of  
bis-(hydrazones) derivative 10 is shown in Scheme 3. 
When  bis-tosylacetylthieno[2,3-b]thiophene derivative 9 were allowed to react with 
benzenediazoniumchloride, which had been prepared in situ from the corresponding aniline in 
hydrochloric acid with aqueous sodium nitrite in dioxane at 0–5 °C, it resulted in  a single product as 
examined by TLC. Elemental analyses and mass spectrum analysis of the isolated product were 
completely in agreement with the molecular formula C40H32O6S4. The structure of the product is 
assumed to be 10a according to the rationale outlined in Scheme 3 in a 76% yield. The structure of 
compound 10a was substantiated from its elemental and spectral analyses. Its IR spectrum showed the 
presence of an absorption band characteristic for NH as well as the presence of C=N absorption at 
3217, and 1627 cm
−1, respectively. The fact that the 
1H NMR of compound 10a was free of tosylacetyl 
protons in the 
1H NMR spectrum strongly supported this assignment. 
Finally, having now available the new bis-tosylacetylthieno[2,3-b]thiophene derivative 9 prompted 
us to study its synthetic utility as a key intermediate for novel symmetrical bis-(hydrazono) 
heterocycles 10b,c. Following the same methodology as described for 10a resulted in the formation of 
the bis-(hydrazone) derivatives 10b and 10c in 81% and 77% yield, respectively, and as depicted in 
Scheme 3. The structures of compounds 10b,c were inferred from different spectroscopic and 
analytical data. Int. J. Mol. Sci. 2012, 13  5039 
 
 
Scheme 3. Synthesis of hydrazonothieno[2,3-b]thiophene derivatives 10a–c. 
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3. Experimental Section  
All melting points were measured on a Gallenkamp melting point apparatus. IR spectra were 
measured as KBr pellets on a Pye-Unicam SP 3–300 spectrophotometer. The NMR spectra were 
recorded on a Varian Mercury VX-400 NMR spectrometer. 
1H-NMR and 
13C-NMR (400 MHz) were 
run in dimethylsulphoxide (DMSO-d6). Chemical shifts were related to that of the solvent. Mass 
spectra were recorded on a Shimadzu GCMS-QP 1000 EX mass spectrometer at 70 eV. Elemental 
analyses was carried out on an Elementar Vario EL analyzer.  
3.1. 2,2'-(4,4'-(3,4'-Dimethylthieno[2,3-b]thiophene-2,5-diyl)Bis(thiazole-4,2 diyl))diacetonitrile (2) 
To a solution of 1 (0.41 g, 1 mmol, 1.0 equiv) in absolute ethanol (20 mL, 99.9%),   
2-cyanoethanethioamide (0.20 g, 2.0 mmol, 2.0 equiv) and TEA (triethylamine) were added (few drops) 
and the resulting mixture was refluxed for 6 h. The solution was allowed to cool to room temperature. 
The formed solid product was filtered off and recrystallized from EtOH/DMF to afford the compound 
2 as black needle crystals; Yield (88%); m.p. 270–272 °C; IR νmax (KBr) 2259 (CN), 1529 (C=N) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) (ppm): 2.21 (s, 6H, CH3), 3.79 (s, 4H, CH2), 7.80 (s, 2H, Thiazol); 
13C-NMR:  δ 14.8, 22.0, 117.4, 116.8, 128.8, 159.3, 134.3, 136.0, 148.1, 148.8; MS m/z (%):   
412 (M
+, 100); Anal. for C18H12N4S4 (412.05) calcd; C, 52.40; H, 2.93; N, 13.58; S, 31.09. Found:  
C, 52.10; H, 2.71; N, 13.28; S, 31.42.  Int. J. Mol. Sci. 2012, 13  5040 
 
 
3.2. General Procedure for the Synthesis of Compounds 3a-c (GP1)  
3.2.1. 4,4'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(thiazole-4,2-Diyl))bis 
(3-aryle acrylonitrile) (3a–c) 
Method A: To a solution of 1 (0.41 g, 1 mmol, 1.0 equiv.) in mixture of absolute ethanol   
(20 mL, 99.9%) and DMF (5 mL), 3-aryle-2-cyanoprop-2-enethioamide (2.0 mmol, 2.0 equiv.) was 
added, and the reaction mixture was then heated under reflux for 6 h. The solution was allowed to cool 
to room temperature. The solid product was collected by filtration and recrystallized from EtOH/DMF 
to afford the compound 3a–c.  
Method B: To a solution of 2 (0.41 g, 1 mmol, 1.0 equiv) in mixture of absolute ethanol   
(20 mL, 99.9%) and DMF (5 mL), aromatic aldehyde derivatives (2 mmol, 2.0 equiv) were added, the 
reaction mixture was then heated under reflux for 6–7 h. The solution was allowed to cool to room 
temperature. The solid product was collected by filtration and recrystallized from EtOH/DMF to afford 
the compound 3a–c.  
3.2.2. 2,2'-(4,4'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5- diyl)bis(triazole -4,2-diyl))bis 
(3-phenylacrylonitrile) (3a) 
3a was prepared according to method A or method B, dark yellow crystals; yield (81
a, 67
b %); m.p. 
300–302 °C; IR νmax (KBr) 2214 (CN), 1591 (C=N) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) (ppm): 
2.28 (s, 6H, CH3), 6.99–7.40 (m, 10H, ArH’s), 8.50 (s, 2H, Ar–CH=C), 8.84 (s, 2H, Thiazol);   
13C-NMR: δ 15.5, 118.0, 113.2, 135.9, 164.5, 106.1, 154.0, 124.0, 125.2, 128.0, 132.0, 138.5, 141.4, 
147.6, 148.2; MS m/z (%): 588 (M
+, 100); Anal. for C32H20N4S4 (588.79) calcd; C, 65.28; H, 3.42; N, 
9.52; S, 21.78. Found: C, 65.06; H, 3.18; N, 9.23; S, 21.12. 
3.2.3. 2,2'-(4,4'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(thiazole-4,2-Diyl))bis 
(3-(4-chlorophenyl)acrylonitrile (3b) 
3b was prepared according to method A or method B, brown needle crystals, yield (75
a, 48
b %); 
m.p. >320 °C; IR νmax (KBr) 2119 (CN), 1570 (C=N) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) (ppm): 
2.36 (s, 6H, CH3), 6.44 (d, 2H, J = 8.4 Hz, ArH’s), (d, 2H, J = 8.4 Hz, ArH’s), 8.48 (s, 2H, Ar–CH=C), 
8.82 (s, 2H, Thiazol), 
13C-NMR: δ 14.1, 117.7, 111.1, 149.5, 162.3, 104.8, 153.2, 122.4, 125.8, 127.3, 
131.2, 134.2, 138.1, 142.5, 147.9; MS m/z (%): 658 (M
++2, 62); Anal. for C32H18N4S4 Cl2 (657.68) 
calcd; C, 58.44; H, 2.76; N, 8.52; S, 19.50. Found: C, 58.14; H, 2.46; N, 8.82; S, 19.20.  
3.2.4. 2,2'-(4,4'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(thiazole-4,2-diyl))bis 
(3-(4-methoxyphenyl)acrylonitrile (3c) 
3c was prepared from according to method A or method B (GP1), dark brown powder crystals; 
yield (88
a, 55
b %); m.p. 282–284 °C; IR νmax (KBr) 2188 (CN), 1579 (C=N) cm
−1; 
1H-NMR (400 MHz, 
DMSO-d6) (ppm): 2.36 (s, 6H, CH3), 3.86 (s, 6H, OCH3), 6.57 (d, 2H, J = 8.4 Hz, ArH’s), 7.21 (d, 2H, 
J = 8.4 ArH’s) 8.43 (s, 2H, Ar–CH=C), 8.87 (s, 2H, Thiazol); 
13C-NMR: δ 14.6, 116.4, 112.45, 148.7, 
164.2, 102.1, 155.8, 123.4, 125.1, 128.8, 129.3, 55.4, 133.8, 137.6, 141.9, 146.3; MS m/z (%): 648 (M
+, Int. J. Mol. Sci. 2012, 13  5041 
 
 
100); Anal. for C32H18N4S4 Cl2 (648.84) calcd; C, 62.94; H, 3.73; N, 8.63; S, 19.77. Found: C, 62.64; 
H, 3.43; N, 8.93; S, 19.47.  
3.3. General Procedure for the Synthesis of Compounds 4a-c (GP2)  
3.3.1. 3,3'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(5-amino-7-aryle-7H-thiazolo[3,2-a]pyridine-
6,8-dicarbonitrile) (4a-c). 
Method A: To a solution of 2 (0.41 g, 1 mmol, 1.0 equiv) in mixture of absolute ethanol   
(20 mL, 99.9%) and DMF (5 mL), 2-arylidenemalo nonitril derivatives (2 mmol, 2.0 equiv) were 
added, the reaction mixture was then heated under reflux for 4 h. The solution was allowed to cool to 
room temperature. The solid product was collected by filtration and recrystallized from EtOH/DMF to 
afford the compound 4a-c. 
Method B: To a solution of 3a-c (1.0 mmol, 1.0 equiv) in mixture of absolute ethanol (20 mL, 99.9%) 
and DMF (5 mL), malononitrile (0.13 mL, 2.0 mmol, 2 equiv) was added, the reaction mixture was then 
heated under reflux for 4–6 h. The solution was allowed to cool to room temperature. The solid product 
was collected by filtration and recrystallized from EtOH/DMF to afford the compound 4a-c. 
3.3.2. 3,3'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(5-amino-7-phenyl-7H-thiazolo 
[3,2-a]pyridine-6,8-dicarbonitrile (4a) 
4a was prepared according to method A or method B (GP2), black light needle crystals; yield (73
a, 
56
b %); m.p. >302 °C; IR νmax (KBr) 3444–3361(NH2 ), 2202, 2188.8 (4CN) cm
−1; 
1H-NMR  
(400 MHz, DMSO-d6) (ppm): 2.21 (s, 6H, CH3), 4.37 (br, 4H, NH2), 5.02 (s, 2H, pyridine), 7.04–7.70 
(m, 10H, ArH’s), 9.08 (s, 2H, Thiazol); 
13C-NMR: δ 13.8, 115.7, 116.9, 112.1, 153.9, 155.0, 33.0, 56.4, 
71.5, 159.8, 123.0, 126.0, 128.9, 134.3, 141.5, 141.9, 148.1, 148.8; MS m/z (%):720 (M
+, 100); Anal. 
for C38H24N8S (720.91) calcd; C, 63.31; H, 3.36; N, 15.54; S, 17.79. Found: C, 63.01; H, 3.06; N, 
15.24; S, 17.49.  
3.3.3. 3,3'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(5-amino-7-(4-chlorophenyl)-7H-
thiazolo[3,2-a]pyridine-6,8-dicarbonitrile (4b) 
4b was prepared according to method A or method B (GP2), greenish yellow scale crystals; yield 
(85
a, 62
b %); m.p. >302 °C; IR νmax (KBr) 3383–3320 (NH2 ), 2241, 2193.2 (4CN) cm
−1; 
1H-NMR 
(400 MHz, DMSO-d6) (ppm): 2.31 (s, 6H, CH3), 4.57 (br,4H, NH2), 4.72 (s, 2H, pyridine), 7.17 (d, 2H, 
J = 8.8 Hz, ArH’s), 7.65 (d, 2H, J = 8.8 Hz, ArH’s), 9.23 (s, 2H, Thiazol); 
13C-NMR: δ 15.2, 117.6, 
118.4, 114.6, 152.5, 155.2, 32.3, 58.2, 73.8, 158.5, 122.7, 125.1, 127.6, 132.3, 142.7, 142.8, 147.5, 
148.1; MS m/z (%):790 (M
+, 18); Anal. for C38H22N8S4 Cl2 calcd; C, 57.79; H, 2.81; N, 14.19; S, 16.24. 
Found: C, 57.49; H, 2.51; N, 13.97; S, 16.54.  
3.3.4. 3,3'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(5-amino-7-(4-methoxyphenyl)-7H-
thiazolo[3,2-a]pyridine-6,8-dicarbonitrile) (4c) 
4c was prepared according to method A or method B (GP2), black shiny powder crystals; yield (68
a, 
44
b %); m.p. >302 °C; IR νmax (KBr) 3410–3315(NH2 ), 2288, 2245 (4CN) cm
−1; 
1H-NMR  Int. J. Mol. Sci. 2012, 13  5042 
 
 
(400 MHz, DMSO-d6) (ppm): 2.28 (s, 6H, CH3), 3.85 (s, 6H, OCH3), 4.18 (br,4H, NH2), 5.23 (s, 2H, 
pyridine), 6.87 (d, 2H, J = 8.8 Hz, ArH’s), 7.12 (d, 2H, J = 8.8 Hz, ArH’s), 9.15 (s, 2H, Thiazol);
  
13C-NMR: δ 13.4, 117.48, 119.11, 111.1, 154.3, 156.09, 34.0, 57.1, 75.1, 159.6, 122.7, 125.1, 127.6, 
132.3, 51.3, 141.2, 142.3, 148.2, 148.4; MS m/z (%): 780 (M
+, 100); Anal. for C40H28N8O2S4 calcd; C, 
61.52; H, 3.61; N, 14.35; S, 16.42. Found: C, 61.22; H, 3.31; N, 14.65; S, 16.20.  
3.4. 1,1'-(2,2'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(2-oxoethane-2,1-diyl))dipyridinium 
Bromide (5) 
To a solution of 1 (0.41 g, 1.0 mmol, 1.0 equiv) in a mixture of absolute ethanol (20 mL, 99.9%) 
and THF (5 mL), pyridine (0.16 mL, 2 mmol, 2.0 equiv) was added, the reaction mixture was then 
heated under reflux for 1 h. The solution was allowed to cool to room temperature. The solid product 
was collected by filtration and recrystallized from EtOH/DMF to afford the compound 5. White 
needles crystals; yield (95 %); m.p. 265–267 °C; IR νmax (KBr) 1636 (C=O ), 1580 (C=N) cm
−1;  
1H-NMR (400 MHz, DMSO-d6) (ppm): 2.14 (s, 6H, CH3), 4.81 (s,4H, CH2), 8.27–9.06 (m, 10H, 
pyridine); 
13C-NMR: δ 15.6, 67.6, 128.1, 128.9, 140.8, 141.6, 146.7, 146.9, 147.5, 147.9; MS m/z (%): 
569 (M
+ +4, 18); Anal. for C22H20Br2N2O2S2 calcd; C, 46.49; H, 3.55; N, 4.63 S, 11.28. Found: C, 
46.19; H, 3.25; N, 4.63; S, 11.08. 
3.5. General Procedure for the Synthesis of Compounds 6a-d (GP3) 
3.5.1. 5,5'-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-dicarbonyl)bis(2-amino-4-aryl-4, 
5-dihydrothiophene-3-carbonitrile) (6a-d) 
To a solution of 5 (0.57 gm, 1.0 mmol, 1.0 equiv) in mixture of absolute ethanol (20 mL, 99.9%) 
and DMF (5 mL), 2-cyano-3-aryle prop-2-enethioamide derivatives (2 mmol, 2.0 equiv) were added; 
the reaction mixture was then heated under reflux for 4 h. The solution was allowed to cool to room 
temperature. The solid product was collected by filtration and recrystallized from EtOH/DMF to afford 
the compound 6a-d. 
3.5.2. 4,4'-5,5'(3,4-Dimethylthieno[2,3-b]thiophene-2,5-dicarbonyl)bis(2-amino-4-phenyl-4, 
5-dihydrothiphene-3-corbonitrile (6a)  
6a was prepared according to (GP3), red light powder crystals; yield (86%); m.p. 300–302 °C; IR 
νmax (KBr) 3450–3348(NH2), 1651 (C=O) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) (ppm): 2.25 (s, 6H, 
CH3), 4.19 (br, 4H, NH2), 4.40 (d, 2H, J = 4.80 Hz, dihydrothiophene), 4.70 (d, 2H, J = 4.20 Hz, 
dihydrothiophene), 7.26–7.39 (m, 10H, ArH’s); 
13C-NMR: δ 14.8, 54.0, 55.2, 72.3, 159.3, 116.8, 123.6, 
124.06, 128.8, 134.3, 136.0, 142.0, 148.1, 148.8, 191.0; MS m/z (%):624 (M
+, 29); Anal. for 
C32H24N4O2S4 calcd; C, 61.51; H, 3.87; N, 8.97; S, 20.53. Found: C, 61.21; H, 3.57; N, 8.67; S, 20.83. Int. J. Mol. Sci. 2012, 13  5043 
 
 
3.5.3. 4,4'-5,5'(3,4-Dimethylthieno[2,3-b]thiophene-2,5-dicarbonyl)bis(2-amino-4-(4-chlorophenyl)-
4,5-dihydrothiphene-3-corbonitrile (6b) 
6b was prepared according to (GP3), dark brown powder crystals; yield (78%); m.p. >320 °C; IR 
νmax (KBr) 3438–3320 (NH2), 1686 (C=O) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) (ppm): 2.37 (s, 6H, 
CH3), 4.42 (br, 4H, NH2), 4.39 (d, 2H, J = 4.80 Hz, dihydrothiophene), 4.82 (d, 2H J = 4.20 Hz, 
dihydrothiophene), 7.12 (d, 2H, J = 8.0 Hz, ArH’s), 7.42 (d, 2H, J = 8.0 Hz, ArH’s); 
13C-NMR: δ 15.6, 
54.6, 56.1, 73.6, 161.1, 117.2, 122.3, 126.1, 133.8, 134.4, 139.6, 146.8, 147.1, 148.4, 188.7;   
MS m/z (%):694 (M
+ +2, 19); Anal. for C32H22Cl2N4O2S4 calcd; C, 55.40; H, 3.20; N, 8.08; S, 18.49. 
Found: C, 55.10; H, 3.50; N, 7.88; S, 18.19.  
3.5.4. 4,4'-5,5'(3,4-Dimethylthieno[2,3-b]thiophene-2,5-dicarbonyl)bis(2-amino-4-(4-hydroxyphenyl)-4,5-
dihydrothiphene-3-corbonitrile (6c) 
6c was prepared according to (GP3), red blessed scale crystals; yield (79%); m.p. >320 °C; IR νmax 
(KBr) 3420–3382(NH2), 1633 (C=O) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) (ppm): 2.81 (s, 6H, CH3), 
5.02 (br, 4H, NH2), 4.30 (d, 2H, J = 4.8 Hz, dihydrothiophene), 4.79 (d, 2H, J = 4.2 Hz, 
dihydrothiophene), 7.26 (d, 2H, J = 8.0 Hz, ArH’s), 7.57 (d, 2H, J = 8.0 Hz, ArH’s), 11.32 (br, 2H, OH); 
13C-NMR: δ 15.4, 55.6, 56.6, 74.0, 152.7, 116.2, 123.2, 127.7, 134.5, 136.8, 142.2, 146.3, 148.1, 148.8, 
190.4; MS m/z (%): 656 (M
+, 100); Anal. for C32H24N4O4S4 calcd; C, 58.52; H, 3.68; N, 8.53; S, 19.53. 
Found: C, 58.22; H, 3.38; N, 8.23; S, 19.23.  
3.5.5. 4,4'-5,5'(3,4-Dimethylthieno[2,3-b]thiophene-2,5-dicarbonyl)bis(2-amino-4-(4-methoxyphenyl)-4,5-
dihydrothiphene-3-corbonitrile (6d) 
6c was prepared according to (GP3), dark yellow powder crystals; yield (81%); m.p. >320 °C; IR νmax 
(KBr) 3433–3364 (NH2), 1710 (C=O) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) (ppm): 2.33 (s, 6H, CH3), 
3.81 (s, 6H, OCH3), 4.88 (br, 4H, NH2), 4.32 (d, 2H, J = 4.8 Hz, dihydrothiophene), 4.66 (d, 2H J = 4.2 
Hz, dihydrothiophene), 6.85 (d, 2H, J = 8.0 Hz, ArH’s), 7.31 (d, 2H, J = 8.0 Hz, ArH’s); 
13C-NMR:  
δ 15.3, 52.3, 56.2, 57.3, 74.24, 158.50, 115.9, 122.7, 128.5, 134.4, 135.8, 143.9, 147.0, 148.1, 148.5, 
192.1; MS m/z (%):684 (M
+, 100); Anal. for C34H28N4O4S4 calcd; C, 59.63; H, 4.12; N, 8.18; S, 18.73. 
Found: C, 59.33; H, 4.42; N, 8.48; S, 18.43.  
3.6. 1,1'-(3,4-Dimethyl-5-(2-tosylacetyl)thieno[2,3-b]thiophen-2-yl)-2-tosylethanone (9) 
To a solution of 8 (0.41 gm, 1.0 mmol, 1.0 equiv) in mixture of absolute ethanol (20 mL, 99.9%) 
and DMF (5 mL), sodium 4-methylbenzenesulfinate (0.35 g, 2 mmol, 2.0 equiv) was added; the 
reaction mixture was then heated under reflux for 4 h. The solution was allowed to cool to room 
temperature. The solid product was collected by filtration and recrystallized from EtOH/DMF to afford 
the compound 9. White cubes crystals; yield (97%); m.p. 263–265 °C; IR νmax (KBr) 2980 (CH2), 1653 
(C=O) cm
−1; 
1H-NMR (40 0 MHz, DMSO-d6) (ppm): 1.50 & 2.73 (s, 12H, CH3), 3.90 (s, 4H, 
Methylene), 6.93 (d, 2H, J = 7.3 Hz, ArH’s), 6.99 (d, 2H, J = 7.3 Hz, ArH’s); 
13C-NMR: δ 15.6, 20.6, 
69.2, 122.0, 122.5, 128.2, 132.0, 138.6, 141.5, 146.0, 147.7, 190.1; MS m/z (%): 560 (M
+, 52); Anal. 
for C26H24O6S4 calcd; C, 55.69; H, 4.31; S, 22.87. Found C, 55.39; H, 4.61; S, 22.67.  Int. J. Mol. Sci. 2012, 13  5044 
 
 
3.7. General Procedure for the Synthesis of Compounds 10a-c (GP4) 
3.7.1. 2-(2-Arylhydrazono)-1-(5-((Z)-2-(2-chlorohydrazono)-2-tosylacetyl)-3,4-dimethylthieno  
[2,3-b]thiophen-2-yl)-2-tosylethanone (10a–c) 
A stirred soln. of 9 (0.5 mmol, 0.28 g) in ethanol (15 mL) was cooled in an ice bath at 0–5 °C,  
and then a soln. of the benzenediazonium chloride [freshly prepared by diazotizing aniline (1 mmol) in 
HCl (0.28 mL) with NaNO2 (2 mmol) in H2O (4 mL)] was added drop-wise over a period of 20 min. 
The reaction mixture was kept in a refrigerator overnight. The solid product was collected by filtration, 
and recrystallized from Et-OH/DMF. Thus pure crystals of the desired compounds 10a–c were 
obtained in a good yield that ranged from 76 to 81%. 
3.7.2. 1-(3,4-Dimethyl-5-2-(2-phenylhydrazono)-2-tosylacetyl)thieno[2,3-b]thiophen-2-yl)-2-(2-
phenylhydrazono)-2-tosylethanone (10a) 
10a was prepared according to (GP4), red light powder crystals; yield (76%); m.p.295–297 °C; IR 
νmax (KBr) 3217 (NH), 1669 (C=O), 1595 (C=N) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) (ppm): 2.14, 
2.79 (s, 12H, CH3), 7.48–7.58 (m, 10H, aromatic), 7.83 (d, 2H, J = 7.3 Hz, ArH’s), 7.85 (d, 2H, J = 7.3 Hz, 
ArH’s) , 8.25 (br, 2H, NH); 
13C-NMR: δ 15.5, 21.6, 119.8, 119.8, 120.0, 120.2, 128.7, 130.2, 135.1, 
138.0, 141.5, 145.3, 148.1, 148.6, 169.0, 185.3; MS m/z (%):768 (M
+, 19); Anal. for C38H32N4O6S4 calcd; 
C, 59.35; H, 4.19; N, 7.29; S, 16.68. Found: C, 59.05; H, 4.49; N, 6.99; S, 16.48. 
3.7.3. 2-(2-(4-Chlorophenyl) hydrazono)-1-(5-2-(2-(4-chlorophenyl) hydrazono)-2-tosylacetyl)-3, 
4-dimethylthieno[2,3-b]thiophen-2-yl)-2-tosylethanone (10b) 
10b was prepared according to (GP4), yellow powder crystals; yield (81%); m.p. >320 °C; IR νmax 
(KBr) 3288 (NH), 1720 (C=O), 1565 (C=N) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.10, 2.86 
(s, 12H, CH3), 7.19 (d, 2H, J = 8.8Hz, ArH’s), 7.28 (d, 2H, J = 8.8 Hz, ArH’s), 7.67 (d, 2H, J = 7.3 Hz, 
ArH’s), 7.80 (d, 2H, J = 7.3 Hz, ArH’s), 12.8 (br, 2H, NH); 
13C-NMR: δ 14.8, 23.5, 121.2, 123.0, 
123.9, 124.0, 126.3, 128.8, 132.4, 136.5, 140.9, 147.5, 147.7, 154.3, 165.2, 190.1; MS m/z (%): 838 
(M
+, 39); Anal. for C38H30Cl2N4O6S4 calcd; C, 54.47; H, 3.61; N, 6.69; S, 15.31. Found: C, 54.17; H, 
3.31; N, 6.39; S, 15.01.  
3.7.4. 1-(3,4-Dimethyl-5-2-(2-(p-tolyl)hydrazono)-2-tosylacetyl)thieno[2,3-b]thiophen-2-yl)-2-(2- 
(p-tolyl)hydrazono)-2-tosylethanone (10c) 
10b was prepared according to (GP4), dark yellow needles crystals; yield (77%); m.p. 300–302 °C; 
IR νmax (KBr) 3356 (NH), 1652 (C=O), 1582 (C=N) cm
−1; 
1H-NMR (400 MHz, DMSO-d6) (ppm): 
2.05, 2.10, 2.86 (s, 18H, CH3), 6.67 (d, 2H, J = 8.8 Hz, ArH’s), 6.81 (d, 2H, J = 8.8 Hz, ArH’s),  
7.62 (d, 2H, J = 7.3 Hz, ArH’s), 7.79 (d, 2H, J = 7.3 Hz, ArH’s), 9.52 (br, 2H, NH); 
13C-NMR: δ 16.0, 
24.2, 24.1, 120.1, 120.9, 122.4, 123.9, 127.8, 128.2, 134.1, 137.6, 142.0, 143.8, 146.6, 152.9, 163.3, 
188.0; MS m/z (%): 796 (M
+, 28); Anal. for C40H36N4O6S4 calcd; C, 60.28; H, 4.55; N, 7.03; S, 16.09. 
Found: C, 60.08; H, 4.25; N, 7.33; S, 16.29. 
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4. Conclusions  
In conclusion, the present investigation describes an efficient method for access toward novel   
bis-heterocycles containing biologically active moieties. We believe that these new series of symmetrical 
bis-hetrocycles may exhibit potentially diverse useful applications in the field of medicinal chemistry.  
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